Chris Cunningham, PhD: Mind-Altering Frontiers- The Cannabis and Psychedelics Conundrum

Dr. Chris Cunningham discusses the complexities of neurochemistry, particularly in relation to pain management and addiction. He shares insights from his research on non-addicting analgesics and the challenges of treating depression. The discussion also covers the future of drug discovery, the role of AI, ethical considerations in neurochemistry, and the individual variations in drug response, particularly with cannabis. The conversation emphasizes the importance of trusted sources in navigating the complexities of drug information and treatment.0:00 Introduction and Regression Towards the Mean7:00 Microdosing LSD for Depression8:56 The Mechanism of LSD and Depression Treatment12:03 Natural Products and Synthetic Compounds16:34 Individual Variations in Response to Cannabis23:30 Impact of Delivery Methods on Cannabis Effects26:40 Introduction and Research Findings31:46 Technology in Molecular Modeling33:51 Advancements in Drug Discovery36:41 Ethical Concerns in Research39:49 Addressing Substance Abuse and Drug Dependency40:19 The Ongoing Battle Against Opioid Overdoses40:35 Researching Non-Addicting Analgesics and Opioid Overdose Agents42:52 Inhibiting a Protein in the Endocannabinoid System47:37 The Role of AI in Drug Discovery50:35 Being an Informed Consumer: Seeking Trusted Sources52:59 The Importance of Critical Thinking55:18 Cultivating Curiosity and Trust in Trusted Sources